贵州三力制药股份有限公司 关于持股5%以上股东减持至5%以下的权益变动提示性公告

Core Points - The equity change is due to Hainan Yuexin Pharmaceutical Investment Partnership's (Yuexin Pharmaceutical) reduction plan, which does not trigger a mandatory takeover [2][4] - After the equity change, Yuexin Pharmaceutical holds 20,490,100 shares, representing 4.999997% of the total share capital, and is no longer a shareholder with over 5% ownership [2][3] - The equity change will not affect the company's controlling shareholder or actual controller [2][4] Summary of Equity Change - The equity change is in line with the previously disclosed reduction plan and does not trigger a mandatory takeover [4] - The reduction does not involve the company's controlling shareholder or actual controller, ensuring no change in control or governance structure [4] - The company has fulfilled its information disclosure obligations regarding this equity change as per relevant regulations [4]